Standards Coordinating Body For Gene Cell And Regenerative Medicin

About Standards Coordinating Body For Gene Cell And Regenerative Medicin

Standards Coordinating Body For Gene Cell And Regenerative Medicin (EIN: 820845002) is a nonprofit organization based in Gaithersburg, MD, classified under NTEE code U20. The organization reported total revenue of $553K and total assets of $120K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Standards Coordinating Body For Gene Cell And Regenerative Medicin's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Analysis Pending

AI enrichment for Standards Coordinating Body For Gene Cell And Regenerative Medicin has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Standards Coordinating Body For Gene Cell And Regenerative Medicin with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Filing History

IRS 990 filing history for Standards Coordinating Body For Gene Cell And Regenerative Medicin showing financial trends over 7 years of public records:

Over 7 years of IRS 990 filings (2017–2023), Standards Coordinating Body For Gene Cell And Regenerative Medicin's revenue has grown by 11.1%, moving from $561K to $624K. Total assets decreased by 83.9% over the same period, from $422K to $68K. Total functional expenses rose by 441%, from $140K to $756K. In its most recent filing year (2023), Standards Coordinating Body For Gene Cell And Regenerative Medicin reported a deficit of $132K, with expenses exceeding revenue. The organization holds $152K in liabilities against $68K in assets (debt-to-asset ratio: 224.8%), resulting in net assets of $-84,611.

Year-by-Year Financial Summary

• 2023: Revenue of $624K, expenses of $756K, and assets of $68K (revenue -21.5% year-over-year).
• 2022: Revenue of $795K, expenses of $897K, and assets of $113K (revenue +11.2% year-over-year).
• 2021: Revenue of $715K, expenses of $987K, and assets of $242K (revenue +163.1% year-over-year).
• 2020: Revenue of $272K, expenses of $840K, and assets of $491K (revenue -60.2% year-over-year).
• 2019: Revenue of $683K, expenses of $904K, and assets of $1.1M (revenue -52.5% year-over-year).
• 2018: Revenue of $1.4M, expenses of $648K, and assets of $1.2M (revenue +156.1% year-over-year).
• 2017: Revenue of $561K, expenses of $140K, and assets of $422K.

Data Sources and Methodology

This transparency report for Standards Coordinating Body For Gene Cell And Regenerative Medicin is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.